Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Stock-based Compensation

v3.23.1
Note 4 - Stock-based Compensation
3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

4.

Stock-Based Compensation

 

For the three-month periods ended March 31, 2023 and 2022, our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was $19,669 and $184,850, respectively. We have not recorded any income tax benefit related to stock-based compensation in either of the three-month periods ended March 31, 2023 and 2022.

 

 

A summary of the status of our stock options as of March 31, 2023, and changes during the three-month period then ended, is presented below.

 

   

Three Months Ended March 31, 2023

 
   

Number of

Options

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Life (in years)

   

Aggregate

Intrinsic

Value

 

Outstanding, January 1, 2023

    702,805     $ 4.42       5.5     $  

Granted

    1,339,500       0.32                  

Cancelled/Forfeited

    (138,350

)

    1.04                  

Expired

    (850

)

    61.60                  

Outstanding, March 31, 2023

    1,903,105     $ 1.75       8.2     $  

Exercisable, March 31, 2023

    569,231     $ 4.92       4.5     $  

 

The weighted average grant date fair value per stock option granted during the three-month period ended March 31, 2023 was $0.24. Key assumptions used in the Black-Scholes option pricing model for stock options granted during the three-month period ended March 31, 2023 were the Company’s stock price, an expected volatility rate of 89.47%, a risk-free rate of 3.87%, and an expected life of 5.95 years.

 

A summary of the status of our unvested restricted stock as of March 31, 2023, and changes during the three-month period then ended, is presented below.

 

   

Three Months Ended

March 31, 2023

 
   

Number of

Shares

   

Weighted

Average

Grant-Date

Fair Value

 

Unvested, January 1, 2023

    90,000     $ 0.99  

Vested

         

 

Unvested, March 31, 2023

    90,000     $ 0.99  

 

As of March 31, 2023, there was $315,029 of total unrecognized compensation expense related to unvested stock-based awards, which we expect to recognize over the remaining weighted average vesting term of 1.95 years.